Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck

doi:10.1002/prca.201300059

Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Malin Nordström, Christer Wingren, Carsten Rose, Anders Bjartell, Charlotte Becker, Hans Lilja, Carl A K Borrebaeck

Research output: Contribution to journal › Article › peer-review

58 Downloads (Pure)

Abstract

Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

Original language	English
Pages (from-to)	951-962
Journal	Proteomics Clinical Applications
Volume	8
Issue number	11-12
DOIs	https://doi.org/10.1002/prca.201300059
Publication status	Published - 2014

Subject classification (UKÄ)

Cell and Molecular Biology

Access to Document

10.1002/prca.201300059

Wiley__Nordstrom_et_al

http://www.ncbi.nlm.nih.gov/pubmed/25196118?dopt=Abstract

Cite this

@article{273a1e2fbf854b4fb55be3304cd7b069,

title = "Identification of plasma protein profiles associated with risk groups of prostate cancer patients.",

abstract = "Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.",

author = "Malin Nordstr{\"o}m and Christer Wingren and Carsten Rose and Anders Bjartell and Charlotte Becker and Hans Lilja and Borrebaeck, {Carl A K}",

year = "2014",

doi = "10.1002/prca.201300059",

language = "English",

volume = "8",

pages = "951--962",

journal = "Proteomics Clinical Applications",

issn = "1862-8354",

publisher = "John Wiley & Sons Inc.",

number = "11-12",

}

TY - JOUR

T1 - Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

AU - Nordström, Malin

AU - Wingren, Christer

AU - Rose, Carsten

AU - Bjartell, Anders

AU - Becker, Charlotte

AU - Lilja, Hans

AU - Borrebaeck, Carl A K

PY - 2014

Y1 - 2014

N2 - Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

AB - Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

U2 - 10.1002/prca.201300059

DO - 10.1002/prca.201300059

M3 - Article

C2 - 25196118

VL - 8

SP - 951

EP - 962

JO - Proteomics Clinical Applications

JF - Proteomics Clinical Applications

SN - 1862-8354

IS - 11-12

ER -

Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this